DE ROSA, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 1.143
EU - Europa 1.018
AS - Asia 406
AF - Africa 67
SA - Sud America 3
OC - Oceania 2
Totale 2.639
Nazione #
US - Stati Uniti d'America 1.137
GB - Regno Unito 276
IT - Italia 185
VN - Vietnam 162
CN - Cina 152
SE - Svezia 144
DE - Germania 105
IN - India 62
IE - Irlanda 58
CH - Svizzera 53
FR - Francia 45
RU - Federazione Russa 45
TG - Togo 29
ZA - Sudafrica 27
UA - Ucraina 26
EE - Estonia 18
FI - Finlandia 18
BG - Bulgaria 16
JO - Giordania 15
BE - Belgio 11
CA - Canada 6
IR - Iran 6
CI - Costa d'Avorio 5
NG - Nigeria 5
GR - Grecia 3
MY - Malesia 3
RO - Romania 3
AU - Australia 2
CL - Cile 2
ES - Italia 2
LB - Libano 2
NL - Olanda 2
PL - Polonia 2
AT - Austria 1
BR - Brasile 1
CZ - Repubblica Ceca 1
HR - Croazia 1
HU - Ungheria 1
KR - Corea 1
PH - Filippine 1
PT - Portogallo 1
SC - Seychelles 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 2.639
Città #
Southend 260
Chandler 188
Dong Ket 162
Fairfield 95
Ashburn 84
Princeton 72
Wilmington 65
Dublin 58
Houston 54
Bern 49
Ann Arbor 45
New York 45
Woodbridge 41
Seattle 33
Lomé 29
Bologna 28
Westminster 28
Padova 27
Cambridge 26
Nanjing 26
Medford 23
Jinan 20
Helsinki 18
Shenyang 18
Saint Petersburg 16
Sofia 16
Amman 15
Mülheim 14
Beijing 13
Berlin 12
San Diego 12
Brussels 11
Hebei 11
Turin 11
Florence 9
Jacksonville 9
Mountain View 9
Pune 9
Changsha 8
Jiaxing 8
Milan 8
Ravenna 8
Fremont 7
Redwood City 7
Tianjin 7
Nanchang 6
Torino 6
Abeokuta 5
Abidjan 5
Dearborn 5
Kuban 5
Monmouth Junction 5
Norwalk 5
Rome 5
Toronto 5
Ardabil 4
Boardman 4
Falls Church 4
Guangzhou 4
Lanzhou 4
Mumbai 4
Castelfranco Emilia 3
Haikou 3
Kunming 3
Ningbo 3
San Mateo 3
San Venanzo 3
Taizhou 3
Zhengzhou 3
Bühl 2
Des Moines 2
Hangzhou 2
Hefei 2
Kilburn 2
Lausanne 2
London 2
Luzzara 2
Olalla 2
Parma 2
Piacenza 2
Rawang 2
Sacramento 2
Taiyuan 2
Boston 1
Bratislava 1
Bremen 1
Budapest 1
Bussolengo 1
Büdelsdorf 1
Canyon 1
Castel Maggiore 1
Cesena 1
City of Westminster 1
Costa Mesa 1
Council Bluffs 1
Den Haag 1
East Elmhurst 1
Fontenay-sous-bois 1
Frankfurt Am Main 1
Fuzhou 1
Totale 1.859
Nome #
Follow-up del cancro del pancreas esocrino 191
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. 181
Antitumoral efficacy of the protease inhibitor gabexate mesilate in colon cancer cells harbouring KRAS, BRAF and PIK3CA mutations 177
Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. 159
Asbestos: a putative risk factor for intrahepatic cholangiocarcinoma 127
Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. 99
Irinotecan toxicity: genes or intestinal microflora? 98
High prevalence of asbestos exposure in bile duct cancer patients 98
Effect of the serine proteases inhibitor gabexate mesylate (GM) on the activity of gemcitabine (G) in cell lines of pancreatic cancer (PC) 98
Metronomic capecitabine in advanced hepatocellular carcinoma patients:a phase II study. 97
KRAS and BRAF mutational status as selective criteria for targeted therapy in cholangiocarcinoma. 97
Clinical safety and efficacy of adjuvant chemotherapy in radically resected cholangiocarcinoma patients. 96
Impact of adjuvant chemotherapy on time to relapse in cholangiocarcinoma. 93
EXPOSURE TO ASBESTOS: A PUTATIVE UNKNOWN RISK FACTOR FOR INTRAHEPATIC CHOLANGIOCARCINOMA 90
Role of adjuvant chemoradiotherapy (CRT) and chemotherapy alone in pancreatic cancer: experience in 25 patients. 88
The Protease Inhibitor Gabexate Mesylate Reduces Invasiveness and Angiogenesis in Pancreatic Cancer Cell Lines, Enhancing Gemcitabine Action 82
Second-line chemotherapy in patients with biliary tract cancer. 81
Metronomic capecitabine as second-line treatment for patients with hepatocellular carcinoma with preserved liver function: A phase II study. 76
The follow-up issues: from the necessity to the opportunity 75
Feasibility of triplets (5-FU, oxaliplatin and irinotecan based) in front and subsequent lines of metastatic colorectal cancer patients. 74
Second-line chemotherapy in biliary tract cancer patients. 74
High-resolution genomic profiling of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) patients identified novel recurrent copy number variations involved in both pathogenesis and resistance to tyrosine kinase inhibitors 73
IMPACT OF MULTIDISCIPLINARY APPROACH ON SURVIVAL OF PATIENTS WITH KLATSKIN TUMOR 70
Genome wide analysis of Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) reveals a recurring deletion of VPREB1 gene which affects B-cell differentiation 67
METRONOMIC CAPECITABINE IN HEPATOCELLULAR CARCINOMA RELAPSE AFTER LIVER TRANSPLANTATION: A RETROSPECTIVE STUDY 65
Metronomic capecitabine in advanced hepatocellualr cacinoma patients who have failed sorafenib: a phase II study 65
Metronomic capecitabine as second-line treatment after sorafenib for hepatocelllular carcinoma. 63
Intestinal microbiota around colorectal cancer genesis 62
Totale 2.716
Categoria #
all - tutte 5.966
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.966


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201955 0 0 0 0 0 0 0 0 0 0 7 48
2019/2020525 121 23 4 32 34 40 53 55 55 28 25 55
2020/2021369 66 14 6 9 3 14 11 21 43 7 7 168
2021/2022586 63 32 20 29 54 35 18 35 17 37 144 102
2022/2023750 85 111 39 89 44 54 10 47 114 22 75 60
2023/2024219 27 28 2 22 12 88 16 8 5 11 0 0
Totale 2.716